Chapter-06 Cyanotic Heart Disease

2004 ◽  
pp. 63-78
Author(s):  
Rani Gera
Keyword(s):  
Heart Disease ◽  
Cyanotic Heart Disease

scholarly journals BILATERAL PHEOCHROMOCYTOMAS IN CYANOTIC HEART DISEASE AFTER FONTAN PALLIATION

2021 ◽  
Vol 77 (18) ◽  
pp. 2975
Author(s):  
Amanda Meredith ◽  
Giselle Suero-Abreu ◽  
Renjit Thomas
Keyword(s):  
Heart Disease ◽  
Cyanotic Heart Disease ◽  
Fontan Palliation

Intranasal dexmedetomidine: the ideal drug for sedation in the pediatric echo lab?

2021 ◽  
pp. 1-5
Author(s):  
David E Saudek ◽  
Deborah Walbergh ◽  
Peter Bartz ◽  
Sara Shreve ◽  
Amy Schaal ◽  
...  
Keyword(s):  
Heart Rate ◽  
Heart Disease ◽  
Chart Review ◽  
Chloral Hydrate ◽  
Vital Signs ◽  
Cyanotic Heart Disease ◽  
Historical Cohort ◽  
Safety And Efficacy ◽  
Attractive Option ◽  
The Ideal

Abstract Background: Intranasal dexmedetomidine is an attractive option for procedural sedation in pediatrics due to ease of administration and its relatively short half-life. This study sought to compare the safety and efficacy of intranasal dexmedetomidine to a historical cohort of pediatric patients sedated using chloral hydrate in a pediatric echo lab. Methods: Chart review was performed to compare patients sedated between September, 2017 and October, 2019 using chloral hydrate and intranasal dexmedetomidine. Vital signs, time to sedation, duration of sedation, need for second dose of medication, rate of failed sedation, and impact on vital signs were compared between groups. Subgroup analysis was performed for those with complex and cyanotic heart disease. Results: Chloral hydrate was used in 356 patients and intranasal dexmedetomidine in 376. Patient age, complexity of heart disease, and duration of sedation were similar. Rates of failed sedation were very low and similar. Average heart rate and minimum heart rate were lower for those receiving intranasal dexmedetomidine than chloral hydrate. Impact on vital signs was similar for those with complex and cyanotic heart disease. No adverse events occurred in either group. Conclusions: Sedation with intranasal dexmedetomidine is comparable to chloral hydrate in regards to safety and efficacy for children requiring echocardiography. Consistent with the mechanism of action, patients receiving intranasal dexmedetomidine have a lower heart rate without morbidity.

Cyanosis and Clipping: Noninfectious Aneurysm in a Patient with 22q11.2 Deletion Syndrome

2021 ◽  
pp. 1-5
Author(s):  
Bhanu Jayanand Sudhir ◽  
Sanjay Honavalli Murali ◽  
Jaypalsinh Gohil ◽  
Rajalakshmi Poyuran ◽  
Manikantan Sethuraman ◽  
...  
Keyword(s):  
Heart Disease ◽  
Cerebral Aneurysms ◽  
Artery Aneurysm ◽  
22Q11.2 Deletion Syndrome ◽  
Neurological Deficits ◽  
Deletion Syndrome ◽  
Anterior Communicating Artery ◽  
Cyanotic Heart Disease ◽  
22Q11.2 Deletion ◽  
Congenital Cyanotic Heart Disease

Noninfectious cerebral aneurysms are rare in patients with congenital cyanotic heart disease. We present a patient with DiGeorge/velocardiofacial syndrome with a complex congenital cyanotic heart disease with a ruptured anterior communicating artery aneurysm. The 10-year-old child was managed by surgical clipping of the aneurysm. Surgical challenges included prominent veins in the Sylvian fissure, difficulty in differentiating arterial and venous bleed, and anesthetic risks. The patient recovered without any neurological deficits. This is the first report of a patient with 22q11.2 deletion syndrome, with a noninfectious cerebral aneurysm.

scholarly journals 15O-water PET for evaluation of cardiopulmonary perfusion in complex cyanotic heart disease

2020 ◽  
Vol 4 (1) ◽  
Author(s):  
S. Madsen ◽  
L. P. Tolbod ◽  
U. M. Mortensen ◽  
G. Andersen ◽  
K. Bouchelouche
Keyword(s):  
Heart Disease ◽  
Cyanotic Heart Disease

Selective coronary angiography via antegrade venous route in congenital cyanotic heart disease

1993 ◽  
Vol 28 (2) ◽  
pp. 179-182 ◽  
Author(s):  
Yunus S. Loya ◽  
Robin J. Pinto ◽  
Dhruman M. Desai ◽  
Usha Sundaram ◽  
Ajit R. Bhagwat ◽  
...  
Keyword(s):  
Heart Disease ◽  
Coronary Angiography ◽  
Cyanotic Heart Disease ◽  
Selective Coronary Angiography ◽  
Congenital Cyanotic Heart Disease

Determinants of platelet count in pediatric patients with congenital cyanotic heart disease: Role of immature platelet fraction

2017 ◽  
Vol 13 (1) ◽  
pp. 118-123 ◽  
Author(s):  
Randa M. Matter ◽  
Iman A. Ragab ◽  
Alaa M. Roushdy ◽  
Ahmed G. Ahmed ◽  
Hanan H. Aly ◽  
...  
Keyword(s):  
Platelet Count ◽  
Heart Disease ◽  
Pediatric Patients ◽  
Cyanotic Heart Disease ◽  
Immature Platelet Fraction ◽  
Congenital Cyanotic Heart Disease

scholarly journals Treatment of cyanotic heart diseases in children

2004 ◽  
Vol 132 (suppl. 1) ◽  
pp. 9-13
Author(s):  
Ida Jovanovic ◽  
Vojislav Parezanovic ◽  
Slobodan Ilic ◽  
Djordje Hercog ◽  
Milan Vucicevic ◽  
...  
Keyword(s):  
Heart Disease ◽  
Mortality Rate ◽  
Surgical Procedures ◽  
Heart Surgery ◽  
Heart Diseases ◽  
Arterial Switch Operation ◽  
Open Heart Surgery ◽  
Age Groups ◽  
Mortality Rates ◽  
Cyanotic Heart Disease

Cyanotic heart diseases are relatively rare, but they are severe and heterogeneous congenital heart diseases, which require complex surgery. Development of different advanced surgical procedures, such as arterial switch operation (ASO), Fontan and its modifications, Norwood etc. operations, as well as better perioperative care significantly improved survival rate and quality of life of these children. The study group included 308 children treated for cyanotic heart disease in Yugoslavia, in the period January 2000 to July 2004. Some of them (239, 77.6%) were treated at the University Children?s Hospital in Belgrade, and others (69, 22.4%) in different institutions abroad. The age of the operated patients varied between 1 day and 19 years (median 12 months). The patients (pts) were divided into four groups, according to the disease and type of the operation. In the whole group of 308 patients treated due to cyanotic heart disease, there were 232 (75.3%) cases with open heart surgery and 76 (24.7%) with closed procedures. The mortality rate was significantly different between disease/operation groups, and age groups. Average mortality rates differed from 11.8% for palliative procedures to 12.5% for complete corrections. Mortality rate and achieved surgical results in treatment of chil?dren with cyanotic heart diseases were significantly worse than those published by leading cardiac surgery centers in the world. However, there is a clear tendency in introducing new surgical procedures, lowering the age at which the operation is done and decreasing the mortality rates.

Sign in / Sign up

Export Citation Format

Share Document